-
1
-
-
37849008993
-
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia
-
Antachopoulos, C., J. Meletiadis, T. Sein, E. Roilides, and T. J. Walsh. 2008. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrob. Agents Chemother. 52:321-328.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 321-328
-
-
Antachopoulos, C.1
Meletiadis, J.2
Sein, T.3
Roilides, E.4
Walsh, T.J.5
-
2
-
-
54049095946
-
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: The challenge of azoles versus echinocandins
-
Arendrup, M. C., S. Perkhofer, S. J. Howard, G. Garcia-Effron, A. Vishukumar, D. Perlin, and C. Lass-Florl. 2008. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob. Agents Chemother. 52:3504-3511.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 3504-3511
-
-
Arendrup, M.C.1
Perkhofer, S.2
Howard, S.J.3
Garcia-Effron, G.4
Vishukumar, A.5
Perlin, D.6
Lass-Florl, C.7
-
5
-
-
33748569923
-
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
-
Denning, D. W., K. A. Marr, W. M. Lau, D. P. Facklam, V. Ratanatharathorn, C. Becker, A. J. Ulman, N. L. Seibel, P. M. Flynn, J. A. H. van Burik, D. N. Buell, and T. F. Patterson. 2006. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J. Infect. 53:337-349.
-
(2006)
J. Infect.
, vol.53
, pp. 337-349
-
-
Denning, D.W.1
Marr, K.A.2
Lau, W.M.3
Facklam, D.P.4
Ratanatharathorn, V.5
Becker, C.6
Ulman, A.J.7
Seibel, N.L.8
Flynn, P.M.9
Van Burik, J.A.H.10
Buell, D.N.11
Patterson, T.F.12
-
6
-
-
0043025344
-
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi
-
Diekema, D. J., S. A. Messer, R. J. Hollis, R. N. Jones, and M. A. Pfaller. 2003. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J. Clin. Microbiol. 41:3623-3626.
-
(2003)
J. Clin. Microbiol.
, vol.41
, pp. 3623-3626
-
-
Diekema, D.J.1
Messer, S.A.2
Hollis, R.J.3
Jones, R.N.4
Pfaller, M.A.5
-
7
-
-
33744461308
-
Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: Inhibition of glucan synthase and reduction of β-D-1, 3 glucan levels in culture
-
Kahn, J. N., M. J. Hsu, F. Racine, R. Giacobbe, and M. Motyl. 2006. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of β-D-1, 3 glucan levels in culture. Antimicrob. Agents Chemother. 50:2214-2216.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 2214-2216
-
-
Kahn, J.N.1
Hsu, M.J.2
Racine, F.3
Giacobbe, R.4
Motyl, M.5
-
9
-
-
35748956729
-
Breakthrough invasive aspergillosis in allogeneic hematopoietic stem cell transplant recipients treated with caspofungin
-
Madureira, A., A. Bergeron, C. Lacroix, M. Robin, V. Rocha, R. Peffault de Latour, C. Ferry, A. Devergie, J. Lapalu, E. Gluckman, G. Socie, M. Ghannoum, and P. Ribaud. 2007. Breakthrough invasive aspergillosis in allogeneic hematopoietic stem cell transplant recipients treated with caspofungin. Int. J. Antimicrob. Agents 30:551-554.
-
(2007)
Int. J. Antimicrob. Agents
, vol.30
, pp. 551-554
-
-
Madureira, A.1
Bergeron, A.2
Lacroix, C.3
Robin, M.4
Rocha, V.5
De Peffault Latour, R.6
Ferry, C.7
Devergie, A.8
Lapalu, J.9
Gluckman, E.10
Socie, G.11
Ghannoum, M.12
Ribaud, P.13
-
10
-
-
9644284471
-
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
-
Maertens, J., I. Raad, G. Petrikkos, M. Boogaerts, D. Selleslag, F. B. Petersen, C. A. Sable, N. A. Kartsonis, A. Ngai, A. Taylor, T. F. Patterson, D. W. Denning, T. J. Walsh, et al. 2004. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin. Infect. Dis. 39:1563-1571.
-
(2004)
Clin. Infect. Dis.
, vol.39
, pp. 1563-1571
-
-
Maertens, J.1
Raad, I.2
Petrikkos, G.3
Boogaerts, M.4
Selleslag, D.5
Petersen, F.B.6
Sable, C.A.7
Kartsonis, N.A.8
Ngai, A.9
Taylor, A.10
Patterson, T.F.11
Denning, D.W.12
Walsh, T.J.13
-
11
-
-
3843088493
-
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species
-
DOI 10.1128/JCM.42.8.3475-3482.2004
-
Odds, F. C., M. Motyl, R. Andrade, J. Bille, E. Canton, M. Cuenca-Estrella, A. Davidson, C. Drussel, D. Ellis, E. Foraker, A. W. Fothergill, M. A. Ghannoum, R. A. Giacobbe, M. Gobernado, R. Handke, M. Laverdiere, W. Lee-Yang, W. G. Merz, L. Ostrosky-Zeichner, J. Peman, S. Perera, J. R. Perfect, M. A. Pfaller, L. Proia, J. H. Rex, M. G. Rinaldi, J. L. Rodriguez- Tudela, W. A. Schell, C. Shields, D. A. Sutton, P. E. Verweij, and D. W. Warnock. 2004. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J. Clin. Microbiol. 42:3475-3482. (Pubitemid 39045669)
-
(2004)
Journal of Clinical Microbiology
, vol.42
, Issue.8
, pp. 3475-3482
-
-
Odds, F.C.1
Motyl, M.2
Andrade, R.3
Bille, J.4
Canton, E.5
Cuenca-Estrella, M.6
Davidson, A.7
Durussel, C.8
Ellis, D.9
Foraker, E.10
Fothergill, A.W.11
Ghannoum, M.A.12
Giacobbe, R.A.13
Gobernado, M.14
Handke, R.15
Laverdiere, M.16
Lee-Yang, W.17
Merz, W.G.18
Ostrosky-Zeichner, L.19
Peman, J.20
Perea, S.21
Perfect, J.R.22
Pfaller, M.A.23
Proia, L.24
Rex, J.H.25
Rinaldi, M.G.26
Rodriguez-Tudela, J.-L.27
Schell, W.A.28
Shields, C.29
Sutton, D.A.30
Verweij, P.E.31
Warnock, D.W.32
more..
-
12
-
-
70349643062
-
The role of echinocandins, extended-spectrum triazoles, and polyenes to treat opportunistic moulds and Candida
-
Patterson, T. F. 2007. The role of echinocandins, extended-spectrum triazoles, and polyenes to treat opportunistic moulds and Candida. Curr. Fungal Infect. Rep. 1:5-11.
-
(2007)
Curr. Fungal Infect. Rep.
, vol.1
, pp. 5-11
-
-
Patterson, T.F.1
-
13
-
-
34447105864
-
Resistance to echinocandins-class antifungal drugs
-
Perlin, D. S. 2007. Resistance to echinocandins-class antifungal drugs. Drug Resist. Updat. 10:121-130.
-
(2007)
Drug Resist. Updat.
, vol.10
, pp. 121-130
-
-
Perlin, D.S.1
-
14
-
-
38149134281
-
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance
-
Pfaller, M. A., L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2008. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J. Clin. Microbiol. 46:150-156.
-
(2008)
J. Clin. Microbiol.
, vol.46
, pp. 150-156
-
-
Pfaller, M.A.1
Boyken, L.2
Hollis, R.J.3
Kroeger, J.4
Messer, S.A.5
Tendolkar, S.6
Diekema, D.J.7
-
15
-
-
35848964834
-
A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus
-
Rocha, E. M. F., G. Garcia-Effron, S. Park, and D. S. Perlin. 2007. A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 51:4174-4176.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 4174-4176
-
-
Rocha, E.M.F.1
Garcia-Effron, G.2
Park, S.3
Perlin, D.S.4
-
16
-
-
0037332131
-
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against Aspergillus spp
-
Serrano Mdel, C., A. Valverde-Conde, M. M. Chavez, S. Bernal, R. M. Claro, J. Peman, M. Ramirez, and E. Martin-Mazuelos. 2003. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against Aspergillus spp. Diagn. Microbiol. Infect. Dis. 45:131-135.
-
(2003)
Diagn. Microbiol. Infect. Dis.
, vol.45
, pp. 131-135
-
-
Serrano Mdel, C.1
Valverde-Conde, A.2
Chavez, M.M.3
Bernal, S.4
Claro, R.M.5
Peman, J.6
Ramirez, M.7
Martin-Mazuelos, E.8
-
17
-
-
39449095735
-
Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America
-
Walsh, T. J., E. J. Anaissie, D. W. Denning, R. Herbrecht, D. P. Kontoyiannis, K. A. Marr, V. A. Morrison, B. H. Segal, W. J. Steinbach, D. A. Stevens, J. A. van Burik, J. R. Wingard, and T. F. Patterson. 2008. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 46:327-360.
-
(2008)
Clin. Infect. Dis.
, vol.46
, pp. 327-360
-
-
Walsh, T.J.1
Anaissie, E.J.2
Denning, D.W.3
Herbrecht, R.4
Kontoyiannis, D.P.5
Marr, K.A.6
Morrison, V.A.7
Segal, B.H.8
Steinbach, W.J.9
Stevens, D.A.10
Van Burik, J.A.11
Wingard, J.R.12
Patterson, T.F.13
|